August 31, 2017 - By Kurt Siggers
Shares of Recipharm AB (publ) (STO:RECI-B) last traded at 87.5, representing a move of -0.28%, or -0.25 per share, on volume of 21,525 shares. After opening the trading day at 88.25, shares of Recipharm AB (publ) traded in a close range. Recipharm AB (publ) currently has a total float of 47.62M shares and on average sees 139,557 shares exchange hands each day. The stock now has a 52-week low of 84.5 and high of 147.
Nasdaq Stockholm: A Nordic Nation’s Pride
Sweden is home to one of the best and most accomplished economies in the world. It is truly a pride of the European Union (EU), especially now that Great Britain has decided to leave the political organization. Recipharm AB (publ) is not very concern for its investors. With the Brexit, the Swedish economy is now more than ever at a more competent position to carry out growth prospects.
Stockholm Stock Exchange or Nasdaq Stockholm
The Nasdaq Stockholm, located in Frihamnen, Stockholm, is the primary stock exchange in Sweden. It is also one of the main stock exchanges in other Nordic countries including Denmark, Finland, Iceland, and Norway.
The Nasdaq Stockholm had been established as early as 1863, making it one of the oldest stock exchange in Europe and in the world as well. Until about the first half of the calendar year 1990, trading on the Nasdaq Stockholm occurs on the floor at the Stockholm Stock Exchange Building. Electronic trading was only launched on June 1, 1990. And now it provides numerous improvements in the common work for Recipharm AB (publ).
Nasdaq, Inc. owns the Nasdaq Stockholm since 2008. Consequently, it is part of Nasdaq Nordic, a subsidiary of Nasdaq founded in 2003. Other stock exchanges overseen by Nasdaq Nordic include the Armenia Stock Exchange or Nasdaq OMX Armenia, the Copenhagen Stock Exchange or Nasdaq Copenhagen, the Helsinki Stock Exchange or Nasdaq Helsinki, the Iceland Stock Exchange or Nasdaq Iceland, the Riga Stock Exchange or Nasdaq Baltic, and the Tallinn Stock Exchange or Nasdaq Baltic.
As of March, more than 300 companies are listed on the Nasdaq Stockholm. In totality, it has a market capitalization of roughly $1.26 trillion.
The regular trading session on the Nasdaq Stockholm begins at 9:00 a.m. and ends at 5:00 p.m.
OMX Stockholm 30 Index (OMXS30)
The OMXS30 is the benchmark Swedish index measuring the top 30 stocks on the Nasdaq Stockholm based on market capitalization. It uses the base value of 125 points, which has a base date of September 1986. The OMXS30 has numerous sectors; and the three biggest sectors include Consumer Services, Financials, and Industrials. OMXS30 guarantee the stability for Recipharm AB (publ) work, as well.
The components of the OMXS30 are reviewed semi-annually in order to guarantee an accurate representation of the Swedish equity market. During rebalancing periods, it is only normal for the OMXS30 to forego some components and welcome new ones. It always depends on the companies’ liquidity, market capitalization, and several other factors.
The OMXS30 has touched its all-time low of 98.86 points in November 1987. The substantial losses are widely attributed to the Black Monday, an occurrence that had shaken the global equity market. It all began when stocks on the Stock Exchange of Hong Kong (SEHK) had significantly declined on October 19, 1987.
Eventually, the OMXS30 was able to recoup from the dark times in global economy history. It has touched its all-time high of 1,719.93 in April 2015.
Today is the best time to enter the European equity market, particularly that of Sweden. And perhaps check some companies like Recipharm AB (publ). With low interest rates, Europe is surely an ideal place for investors to bet on through the Nasdaq Stockholm.
More notable recent Recipharm AB (publ) (STO:RECI-B) news were published by: Businesswire.com which released: “Recipharm AB: Recipharm completes acquisition of Kemwell AB and Cirrus …” on May 23, 2016, also Businesswire.com with their article: “Recipharm AB: Recipharm completes acquisition of a majority stake in Indian …” published on April 11, 2016, Businesswire.com published: “Recipharm AB: Recipharm creates a global CDMO leader through SEK 1.7 billion …” on April 18, 2016. More interesting news about Recipharm AB (publ) (STO:RECI-B) were released by: Businesswire.com and their article: “Change in the total number of shares and votes in Recipharm AB (publ)” published on June 30, 2016 as well as Businesswire.com‘s news article titled: “Recipharm AB: Recipharm announces cost and efficiency program in Sweden” with publication date: October 08, 2015.
Recipharm publ AB is a Sweden-based pharmaceutical company, operating as a Contract Development and Manufacturing Organization . The company has market cap of $4.17 billion. It is divided in two business areas: Manufacturing Services, supplying a range of pharmaceutical products in different dosage forms, such as solid dose, semi solids, beta-lactams, hormones, dry powder metered dose inhalers, oral liquids and granulates, among others; and Development and Technology, offering clinical supply, product development, formulation, analytical development, stability studies, packaging development and raw material selection, as well as regulatory advice. It has a 36.04 P/E ratio. It is also engaged in the development of own product portfolio.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.